NCT00002299View on ClinicalTrials.gov

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Interferon beta-1b

DRUG

Ganciclovir

Trial Locations (6)

77550

Univ TX Galveston Med Branch, Galveston

90033

USC, Los Angeles

92668

UCI Med Ctr, Orange

94115

Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco

94305

Stanford Univ School of Medicine, Stanford

921036325

Univ of California / San Diego Treatment Ctr, San Diego

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY